The Pain, Confusion, and Costs of Prior Authorization
By Deanne Kasim – With the increase in specialty drugs, innovative diagnostic testing, and precision medicine, it is expected that the use of the Prior Authorization will only increase with health insurance companies. Of course I have heard from many re: the (theoretical) fact that as the use of value-based provider reimbursement matures, there will be less and less need for a PA process.
Read More